| Dr Barbara Holzknecht Briscoe, OD | |
|
22400 S Salamo Rd, West Linn, OR 97068-8269 | |
| (503) 722-7737 | |
| (503) 722-4152 |
| Full Name | Dr Barbara Holzknecht Briscoe |
|---|---|
| Gender | Female |
| Speciality | Optometry |
| Experience | 32 Years |
| Location | 22400 S Salamo Rd, West Linn, Oregon |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1780673996 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 3009AT (Oregon) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Summit Eyecare Llc | 5294972246 | 3 |
News Archive
Igor F. Tsigelny, Ph.D., Co-founder and Chief Strategic Officer at CureMatch and research professor at University of California, San Diego, is a co-author of "Genomic landscape of cell-free DNA in patients with colorectal cancer" in Cancer Discovery along with group of colleagues from Duke University Medical Center, University of Texas MD Anderson Cancer Center, Massachusetts General Hospital Cancer Center and Department of Medicine, Harvard Medical School, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, Caris Life Sciences, and Guardant Health, Inc. organized by the Drs. Ryan B. Corcoran and Scott Kopetz.
Apexigen, Inc., an emerging biopharmaceutical company focusing on the development of monoclonal antibody therapeutics, announced today that its partner, Simcere Pharmaceutical Group, a leading pharmaceutical company in China, filed an Investigational New Drug application with the State Food and Drug Administration of China to evaluate APX003 as a potential cancer therapy.
A new study presented today at the IOF Regionals 4th Asia-Pacific Osteoporosis Meeting in Hong Kong supports widespread evidence that individuals who have suffered a fracture are at significantly increased risk of subsequent hip fractures. In fact, previous studies have shown that half of patients presenting with hip fractures have suffered a prior fracture.
Acute lymphoblastic leukemia (ALL) is a malignant disease caused by the abnormal growth and development of white blood cells (WBC) in the bone marrow and blood. ALL is the most common cancer occurring in children with an annual rate of approximately 30 to 40 new cases per million.
Modern life, with its preponderance of inadequate exposure to natural light during the day and overexposure to artificial light at night, is not conducive to the body's natural sleep/wake cycle.
› Verified 9 days ago
| Provider Name | Summit Eyecare Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1518204692 PECOS PAC ID: 5294972246 Enrollment ID: O20130510000166 |
News Archive
Igor F. Tsigelny, Ph.D., Co-founder and Chief Strategic Officer at CureMatch and research professor at University of California, San Diego, is a co-author of "Genomic landscape of cell-free DNA in patients with colorectal cancer" in Cancer Discovery along with group of colleagues from Duke University Medical Center, University of Texas MD Anderson Cancer Center, Massachusetts General Hospital Cancer Center and Department of Medicine, Harvard Medical School, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, Caris Life Sciences, and Guardant Health, Inc. organized by the Drs. Ryan B. Corcoran and Scott Kopetz.
Apexigen, Inc., an emerging biopharmaceutical company focusing on the development of monoclonal antibody therapeutics, announced today that its partner, Simcere Pharmaceutical Group, a leading pharmaceutical company in China, filed an Investigational New Drug application with the State Food and Drug Administration of China to evaluate APX003 as a potential cancer therapy.
A new study presented today at the IOF Regionals 4th Asia-Pacific Osteoporosis Meeting in Hong Kong supports widespread evidence that individuals who have suffered a fracture are at significantly increased risk of subsequent hip fractures. In fact, previous studies have shown that half of patients presenting with hip fractures have suffered a prior fracture.
Acute lymphoblastic leukemia (ALL) is a malignant disease caused by the abnormal growth and development of white blood cells (WBC) in the bone marrow and blood. ALL is the most common cancer occurring in children with an annual rate of approximately 30 to 40 new cases per million.
Modern life, with its preponderance of inadequate exposure to natural light during the day and overexposure to artificial light at night, is not conducive to the body's natural sleep/wake cycle.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Barbara Holzknecht Briscoe, OD 3985 S Roxbury Dr, West Linn, OR 97068-8296 Ph: (503) 656-1947 | Dr Barbara Holzknecht Briscoe, OD 22400 S Salamo Rd, West Linn, OR 97068-8269 Ph: (503) 722-7737 |
News Archive
Igor F. Tsigelny, Ph.D., Co-founder and Chief Strategic Officer at CureMatch and research professor at University of California, San Diego, is a co-author of "Genomic landscape of cell-free DNA in patients with colorectal cancer" in Cancer Discovery along with group of colleagues from Duke University Medical Center, University of Texas MD Anderson Cancer Center, Massachusetts General Hospital Cancer Center and Department of Medicine, Harvard Medical School, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, Caris Life Sciences, and Guardant Health, Inc. organized by the Drs. Ryan B. Corcoran and Scott Kopetz.
Apexigen, Inc., an emerging biopharmaceutical company focusing on the development of monoclonal antibody therapeutics, announced today that its partner, Simcere Pharmaceutical Group, a leading pharmaceutical company in China, filed an Investigational New Drug application with the State Food and Drug Administration of China to evaluate APX003 as a potential cancer therapy.
A new study presented today at the IOF Regionals 4th Asia-Pacific Osteoporosis Meeting in Hong Kong supports widespread evidence that individuals who have suffered a fracture are at significantly increased risk of subsequent hip fractures. In fact, previous studies have shown that half of patients presenting with hip fractures have suffered a prior fracture.
Acute lymphoblastic leukemia (ALL) is a malignant disease caused by the abnormal growth and development of white blood cells (WBC) in the bone marrow and blood. ALL is the most common cancer occurring in children with an annual rate of approximately 30 to 40 new cases per million.
Modern life, with its preponderance of inadequate exposure to natural light during the day and overexposure to artificial light at night, is not conducive to the body's natural sleep/wake cycle.
› Verified 9 days ago
West Linn Vision Center Inc Optometrist Medicare: Medicare Enrolled Practice Location: 2020 8th Ave, Suite A, West Linn, OR 97068 Phone: 503-652-1479 Fax: 503-303-5587 | |
Forbes Optical Pc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2020 8th Ave Ste A, West Linn, OR 97068 Phone: 503-652-1479 | |
Eleanor Munoz Llc Optometrist Medicare: Medicare Enrolled Practice Location: 18750 Willamette Dr, West Linn, OR 97068 Phone: 503-697-8879 Fax: 503-650-5357 | |
Dr. Matthew Pearce, OD, MPH Optometrist Medicare: Accepting Medicare Assignments Practice Location: 5656 Hood St Ste 107, West Linn, OR 97068 Phone: 503-723-3000 | |
Eyedeology, Inc Optometrist Medicare: Medicare Enrolled Practice Location: 5656 Hood St. Ste 107, West Linn, OR 97068 Phone: 808-799-4555 | |
Dr. William Todd Briscoe, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 22400 S Salamo Rd, West Linn, OR 97068 Phone: 503-722-7737 Fax: 503-722-4152 | |
Modern Eyez Inc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 18750 Willamette Dr Ste C, West Linn, OR 97068 Phone: 503-697-8879 |